, Tracking Stock Market Picks
Enter Symbol:
Cerus Corporation (CERS) [hlAlert]

up 31.46 %

Cerus Corporation (CERS) rated Buy with price target $6 by Cantor Fitzgerald

Posted on: Wednesday,  Apr 24, 2013  10:25 AM ET by Cantor Fitzgerald

Cantor Fitzgerald rated Buy Cerus Corporation (NASDAQ: CERS) on 04/24/2013. Previously Cantor Fitzgerald rated Buy Cerus Corporation (NASDAQ: CERS) on 04/17/2012.,
when the stock price was $3.75. Since then, Cerus Corporation has gained 31.47% as of 01/07/2016's recent price of $4.93.
If you would have followed the previous Cantor Fitzgerald's recommendation on CERS, you would have gained 31.46% of your investment in 1360 days.

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.

Cantor U.S. Equity Research provides timely and insightful opinions on select stocks. We look at key drivers of the stock price, including company and industry fundamentals, capital markets influences and overall economic trends to provide critical and in-depth analysis. Our focus is on small and mid-cap companies in the following sectors: * Marine Transportation * Life Sciences * Clean Technology & Energy Efficiency * Real Estate * Communications Technology * Internet * Enterprise Software
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/24/2013 10:25 AM Buy
5.17 6.00
as of 12/13/2013
1 Week down  -8.80 %
1 Month down  -3.55 %
3 Months up  1.06 %
1 YTD up  80.37 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/17/2012 8:25 AM Buy
3.75 5.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy